Table. 1.
The correlation between LINC00261 expression and clinicopathological features of patients with pancreatic cancer from TCGA database.
| Characteristics | n = 157 | Expression of linc00261 | P value | |
|---|---|---|---|---|
| Low expression | High expression | |||
| Gender | ||||
| Male | 86 (54.8%) | 40 (46.5%) | 46 (53.5%) | 0.294 |
| Female | 71 (45.2%) | 39 (54.9%) | 32 (45.1%) | |
| Age (years) | ||||
| ≥60 | 111 (70.7%) | 55 (49.5%) | 56 (50.5%) | 0.765 |
| <60 | 46 (29.3%) | 24 (52.2%) | 22 (47.8%) | |
| Pathologic stage | ||||
| I | 18 (11.5%) | 5 (27.8%) | 13 (72.2%) | 0.034* |
| II | 132 (84.1%) | 77 (58.3%) | 55 (41.7%) | |
| III + IV | 7 (4.5%) | 5 (71.4%) | 2 (28.6%) | |
| T stage | ||||
| T1 + T2 | 29 (18.5%) | 11 (37.9%) | 18 (62.1%) | 0.103 |
| T3 + T4 | 128 (81.5%) | 70 (54.7%) | 58 (45.3%) | |
| N stage | ||||
| N0 | 46 (29.3%) | 22 (47.8%) | 24 (52.2%) | 0.801 |
| N1 | 65 (41.4%) | 32 (49.2%) | 33 (50.8%) | |
| N2 | 46 (29.3%) | 25 (54.3%) | 21 (45.7%) | |
| M stage | ||||
| M0 | 76 (48.4%) | 41 (53.9%) | 35 (46.1%) | 0.378 |
| M1 + Mx | 81 (51.6%) | 38 (46.9%) | 43 (53.1%) | |
| R stage | ||||
| R0 | 102 (65.0%) | 46 (45.1%) | 56 (54.9%) | 0.075 |
| R1 + R2 | 55 (35.0%) | 33 (60.0%) | 22 (40.0%) | |
TCGA The Cancer Genome Atlas.
*P < 0.05 was considered to denote statistical significance.